Friday 6 November 2026 Export ZCMD’s income statement to Excel — free account

Zhongchao Inc.

ZCMD Healthcare Health Information Services

Zhongchao Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, down 28.3% from fiscal 2024.

0.97 0.01 +1.04%

Follow ZCMD

Alert me

Market cap: $4.3M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: 3/9
Altman Z: 4.34
Beneish M: −4.20
Dividend safety: n/a

Overview

Insider Decisions last twelve months

Trades a month
	Jan 26			Apr 26			Jul 26			Oct 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 88.17%

Capital & Financial Ratios $m

Size

Market Cap 4.25

Revenue ttm 32.21

Net income ttm (6.77)

Free cash flow ttm (4.10)

Net debt Q (17.34)

Valuation

P/E 0.00

Forward P/E —

Price / sales 0.00

Forward P/S Powerpack

Price / FCF 0.00

Price / book 0.00

Financial health

Current ratio Q 43.35

Debt / equity Q 0.00

Interest coverage Q —

Growth

Revenue growth Q +20.44%

Operating income growth Q —

EPS, this year —

EPS, next year A —

Revenue, next year A +20.94%

EPS, past 5 yrs —

EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years

EV/FCF against its own 10 years 60.55%

10-year low 10-year high

Dividends

Yield: —
Annual rate: —
Payout ratio: —

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	13	13	14	17
Receivables	3	5	3	1
Inventory	1	1	—	—
Other	0	0	0	—
	19	19	17	19

	2023	2024	2025	Q'26
Payables	1	1	1	0
ST’ Debt	—	—	—	—
Other	1	0	0	—
	3	2	2	0

Compound Annual Growth %

	10y	5y	3y
Sales	—	(8.76%)	(7.02%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	(6.62%)	(11.87%)

EPS $

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(343.69)
’24	—	—	—	—	(178.35)
’23	—	—	—	—	(6.47k)
’22	—	—	—	—	(1.63k)
’21	—	—	—	—	148.62
’20	—	—	—	—	2.68k

Fiscal quarters ending in the months shown.

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	11
’24	—	—	—	—	16
’23	—	—	—	—	19
’22	—	—	—	—	14
’21	—	—	—	—	16
’20	—	—	—	—	18

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	1
’24	—	—	—	—	(1)
’23	—	—	—	—	0
’22	—	—	—	—	(1)
’21	—	—	—	—	3
’20	—	—	—	—	(1)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	2	—	1	1
’24	—	(1)	—	(5)	(5)
’23	—	(2)	—	(1)	(1)
’22	—	(1)	—	(1)	(1)
’21	—	0	—	1	1
’20	—	(3)	—	(1)	(1)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM Jun ’26	Trend	10 yrs	2026e	2027e	2028e	Next 3/yr
													Ten-year view		Analyst estimates Powerpack
Income, $m
Income, $m	Revenue	—	10	13	15	18	16	14	19	16	11	32		+1.9%	—	—	—	—
	Gross margin, %	—	59.56	65.36	68.72	65.99	57.92	44.92	43.80	56.18	45.02	45.49		(14.5) pt	Powerpack Zhongchao Inc.’s next three years, line by line See the consensus for every other line: earnings, margins, cash flow, valuation and returns. Unlock estimates Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time. Also in Powerpack: every quarter, Excel exports, API & MCP access. Compare plans
	EBT	—	1	4	4	5	0	(3)	(12)	0	(6)	(9)		n/m
	EBT margin, %	—	13.66	27.23	29.48	27.47	(0.68)	(18.02)	(61.63)	0.39	(50.71)	(27.59)		(64.4) pt
	Net income	—	0	3	4	4	0	(3)	(11)	0	(6)	(7)		n/m
Per share, $
Per share, $	Revenue	—	0.39	9,189.93	9,921.87	11,243.63	9,586.35	8,324.41	10,796.61	4,532.80	618.21	0.00		+151.0%
	Earnings	—	0.06	2,148.36	2,823.81	2,675.19	148.62	(1,634.84)	(6,465.04)	(178.35)	(343.69)	(0.33)		n/m
	Cash flow	—	(0.02)	937.57	938.67	(648.62)	1,683.41	(389.24)	30.11	(420.91)	45.95	0.00		n/m
	Capex	—	0.00	(776.14)	(875.27)	(100.37)	(1,058.76)	(296.18)	(448.94)	(870.06)	(8.29)	0.00		n/m
	Free cash flow	—	(0.02)	161.43	63.40	(749.00)	624.65	(685.41)	(418.83)	(1,290.97)	37.65	0.00		n/m
	Book value	—	0.21	8,132.43	10,225.67	19,896.31	19,156.71	19,423.12	11,687.89	6,900.31	1,228.15	0.00		+196.1%
	Shares, m	—	25	0	0	0	0	0	0	0	0	—		(59.4%)
Valuation, ×
Valuation, ×	P/E	—	25.00	25.00	25.00	74,396.29	139,395.16	0.00	0.00	0.00	0.00	0.00		23,762.9
	P/S	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.0
	P/B	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.0
	EV/Sales	—	0.00	0.00	0.00	(0.50)	(0.39)	(0.37)	(0.39)	(0.38)	(0.41)	(0.52)		(0.3)
	EV/FCF	—	0.00	0.00	0.00	2.94	4.63	9.54	2.76	1.47	3.22	4.05		2.7
Cash, $m
Cash, $m	Operating cash flow	—	(1)	1	1	(1)	3	(1)	0	(1)	1	2		n/m
	Capex	—	0	(1)	(1)	0	(2)	(1)	(1)	(3)	0	(6)		+8.1%
	Free cash flow	—	(1)	0	0	(1)	1	(1)	(1)	(5)	1	(4)		n/m
Balance, $m
Balance, $m	Working capital	—	5	10	12	27	24	19	16	17	15	18		+15.6%
	Net debt	—	(5)	(8)	(8)	(17)	(14)	(12)	(13)	(13)	(14)	(17)		+14.2%
	Shareholders’ equity	—	5	11	15	32	33	33	21	24	23	25		+20.1%
Returns, %
Returns, %	ROA	—	14.55	42.99	25.46	16.97	0.67	(7.85)	(35.97)	(2.56)	(25.22)	0.00		(39.8) pt
	ROIC	—	0.00	67.54	30.33	19.05	(1.09)	(8.80)	(109.36)	(1.93)	(44.60)	0.00		(44.6) pt
	ROE	—	18.40	36.39	30.29	18.90	0.74	(8.97)	(41.94)	(2.85)	(27.00)	0.00		(45.4) pt
People
People	Employees	—	—	90	91	88	136	109	142	111	33	—		(13.4%)
	Revenue/emp, $m	—	0.00	0.14	0.16	0.20	0.12	0.13	0.14	0.14	0.34	—		n/m

Negative figures in brackets.

estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jan 0001 · fundamentals updated 3 Nov 2026

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
BFRG Bullfrog AI Holdings Inc.	$9.1M	— (loss-making)	— (loss-making)	+2,054.00% (above 0%: growing)	n/m	−5.67% (below 0%: shrinking)	49.63%	(658.82%)	Compare
HLTHQ Cue Health Inc.	$6.9M	— (loss-making)	— (loss-making)	−87.19% (below 0%: shrinking)	n/m	+50.55% (above 0%: growing)	(90.14%)	(792.13%)	Compare
ACON Aclarion, Inc.	$4.5M	— (loss-making)	— (loss-making)	+78.48% (above 0%: growing)	n/m	−74.22% (below 0%: shrinking)	43.86%	(8,164.70%)	Compare
MGRX Mangoceuticals, Inc.	$4.3M	— (loss-making)	—	−59.07% (below 0%: shrinking)	n/m	+79.27% (above 0%: growing)	64.24%	(1,501.45%)	Compare
ZCMD Zhongchao Inc.	$4.3M	— (loss-making)	—	+20.44% (above 0%: growing)	−550.00% (below 0%: shrinking)	+191.85% (above 0%: growing)	41.67%	0.00%
HCTI Healthcare Triangle, Inc.	$3.2M	0.0×	— (loss-making)	+158.38% (above 0%: growing)	n/m	+67.48% (above 0%: growing)	22.48%	(44.28%)	Compare
VSEE VSee Health, Inc.	$2.8M	— (loss-making)	— (loss-making)	−53.93% (below 0%: shrinking)	n/m	−257.62% (below 0%: shrinking)	13.20%	(172.69%)	Compare
WORX SCWorx Corp.	$2.0M	— (loss-making)	— (loss-making)	+3.43% (above 0%: growing)	n/m	+87.99% (above 0%: growing)	46.80%	(17.14%)	Compare
MSPR MSP Recovery, Inc.	$1.5M	— (loss-making)	—	−94.60% (below 0%: shrinking)	n/m	+60.88% (above 0%: growing)	(26.77%)	(62,501.52%)	Compare
Median of peers	$3.7M	—	—	−25.25%	—	+55.72%	33.17%	(725.47%)

All 44 Health Information Services stocks →

Zhongchao Inc. (ZCMD) Latest News

29 May

Impact 3 · 10:00 AM · PR Newswire

Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering

4 Feb

Impact 3 · 10:30 AM · Associated Press Finance

BC-Most Active Stocks

4 Oct

Impact 4 · 8:57 AM · Simply Wall St.

Companies Like Zhongchao (NASDAQ:ZCMD) Are In A Position To Invest In Growth

27 Apr

Impact 3 · 8:06 AM · Simply Wall St.

We're Keeping An Eye On Zhongchao's (NASDAQ:ZCMD) Cash Burn Rate

Impact 3 · 8:04 AM · Simply Wall St.

Zhongchao Full Year 2024 Earnings: US$0.12 loss per share (vs US$4.35 loss in FY 2023)

3 May

Impact 4 · 6:20 AM · Simply Wall St.

Zhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022)

12 Mar

Impact 4 · 8:30 AM · PR Newswire

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

27 Feb

Impact 3 · 8:00 AM · PR Newswire

Zhongchao Inc. Announces 1-for-10 Share Consolidation